Goldman Sachs Group Inc Eucrates Biomedical Acquisition Corp. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 May 14, 2024	SELL	$0.02 - $0.08 $2,688 - $10,752	-134,400 Reduced 84.3%	25,033 $1,000
Q4 2022 Feb 13, 2023	SELL	$0.02 - $0.08 $2,688 - $10,752	-134,400 Reduced 84.3%	25,033 $1,000
Q3 2022 May 14, 2024	SELL	$0.04 - $9.95 $8 - $1,989	-200 Reduced 0.13%	159,433 $4,000
Q3 2022 Nov 10, 2022	SELL	$0.04 - $9.95 $8 - $1,989	-200 Reduced 0.13%	159,433 $0
Q2 2022 May 14, 2024	BUY	$9.85 - $9.91 $1.57 Million - $1.58 Million	159,633 New	159,633 $5,000
Q2 2022 Aug 15, 2022	SELL	$9.85 - $9.91 $63,040 - $63,424	-6,400 Reduced 3.85%	159,633 $5,000
Q1 2022 May 16, 2022	BUY	$9.76 - $9.85 $1.62 Million - $1.64 Million	166,033 New	166,033 $31,000

Others Institutions Holding EUCRW

# of Institutions

1

Shares Held

78.1K

Call Options Held

0

Put Options Held

0

Health Cor Management, L.P. New York, NY

78.1K
Shares

$0
0.0% of portfolio

About Eucrates Biomedical Acquisition Corp.

Ticker EUCRW
Exchange NASDAQ

More about EUCRW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.